◆ 会议时间：2025年4月17-19日
◆ 会议地点：韩国 首尔/Seoul

◆ 会议简介：

2025年世界乳腺癌学术大会(GBCC2025)将于2025年4月17-19日在韩国首尔举行。

全球乳腺癌大会(GBCC)起始于2007年，是在韩国召开的亚洲最大最具影响力的乳腺癌会议之一，会议由韩国乳腺癌学会主办、韩国乳腺癌基金会支持，每年乳腺癌领域的众多专家学者聚集一堂，共同探讨有效诊断和治疗乳腺癌以及提高妇女健康的科学方法；GBCC原为每两年举办一次，自2016年开始，改为每年举办一次。GBCC汇聚了包括医学人士、科研人员、政策制定者、患者和监护人等来自社会各届宣的专业人士，共同探讨多种科学策略，有效地诊断和治疗乳腺癌，促进妇女健康。每届GBCC都有来自世界各地的一千三百余名专业人士与会。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。

世界乳腺癌学术大会
GBCC 2025 - Global Breast Cancer Conference 2025

Date:
April 17 (Thu) – 19 (Sat), 2025

Venue:
Grand Walkerhill Seoul, Korea

Hosted by:
Korean Breast Cancer Society

摘要征文投稿：

• Abstract Submission Open: November 1, 2024
• Abstract Submission Deadline: January 24th (Fri.) 23:59 KST, 2025
• Notification of Acceptance: In Mid of March, 2025

点此提交摘要>>>Submit Abstract>>>

Abstract Format

• Abstracts should be submitted online in English.

• The abstract structure should be as follows:
  - Abstract should be structured into the following headings: Background, Methods, Result, and Conclusion.
  - Abstract should not exceed 300 words. (Excluding Abstract Title and Spaces)

• The maximum number of authors is 30 per abstract.

• Figure, Table, Reference and Keyword are not allowed.

• If an author is affiliated with hospital as well as university, please enter the name of the hospital for which he/she works.

Conflicts of Interest

• The conflict of interest policy requirements applies to all abstract authors. Any potential conflict of interest must be indicated upon abstract submission. It is the responsibility of the Presenting Author to obtain disclosure information from all co-authors and to provide disclosure of all interests and relationships. This includes any financial or other relationships with commercial entities whose products or services are related to the subject matter in the manuscript, or sociopolitical issues that can cause conflict.

Encore Abstract Submission

• We are accepting Trial-in-Progress submissions and encore submissions.

• Encore submissions must:

  Have been presented solely in abstract form, including publication in conference proceedings. (Submissions which was already published in the full publication form in journals are NOT accepted.

  Include significant additional data from the previous presentation (as determined by the review committee).

  Include the abstract title, co-authors listed, the full abstract, and indicate if this is an encore presentation and, if so, where it was previously presented. This information should be presented both in abstract and in poster.

• It is the sole responsibility of the author to follow these rules.

• The first author will be responsible for obtaining, and, upon request, showing proof that written permission has been obtained from the copyright holder of the original abstract publication(s).

• Please note that encore abstracts can be disadvantaged in selecting awards and scholarships.

Acceptance Notification

• Abstract acceptance will be notified by e-mail.

• The decision of the Scientific Committee on abstract acceptance is final. While authors’ preferences for oral or poster presentations will be considered, the committee may offer an alternative format. No correspondence on their decision can be initiated by the authors.

• The first author or corresponding author should reply to the notification of acceptance of their abstract for attendance confirmation.

Abstract Modification or Withdrawal

• You can modify or withdraw your abstract on the submission online page within deadline.

• The request for modification or withdrawal after the abstract submission deadline must be submitted through email (gbccabs@intercom.co.kr).

• The first author or corresponding author may request a correction of error (e.g., typos, misspellings, grammatical errors).

• If the presenting author does not register for GBCC 2025 by the registration deadline, his/her abstract will be automatically withdrawn.

Dear Colleagues,

Welcome to the Global Breast Cancer Conference 2025 (GBCC 2025), scheduled from April 17 (Thu.) to 19 (Sat.), 2025, at the Grand Walkerhill Seoul, Korea.

The Global Breast Cancer Conference (GBCC) addresses multidisciplinary topics related to breast cancer, which has the highest incidence rate worldwide. This conference was established to fulfill the need for an academic event representing Korea and Asia. As one of the largest breast cancer conferences in Asia, GBCC aims to lead the region and boasts strong international networks.

Since its successful inception in 2007, GBCC has convened annually, bringing together experts from diverse fields to develop multidisciplinary strategies for the effective diagnosis and treatment of breast cancer, ultimately advancing women's health.

GBCC 2024 attracted 3,842 participants from 60 countries, marking a 166% increase over the past five years. We were honored to host 195 speakers and experts from 16 countries across 63 sessions.

GBCC 2025 will further expand the scope of breast cancer research, striving to become a comprehensive academic conference covering all aspects of breast cancer research. Join us in opening new horizons for breast cancer research, strengthening cooperation and networking between domestic and international organizations, and striving for a world without breast cancer.

We would be honored to have you join us on this remarkable journey at GBCC 2025, and we look forward to welcoming you in April.
Thank you.

注册费：

Registration Fee

* Fellow/Clinical Instructor: Please register as a Physician category.
* Accompanying Person registration is limited to spouses and can only attend the Opening Ceremony, Exhibition and Welcome Dinner.
* GBCC Robotic Surgery Workshop participants will be selected under a set of evaluation.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。